David Huang

Title: The Innovations of David Huang

Introduction

David Huang is an accomplished inventor based in Durham, NC (US). He has made significant contributions to the field of biomedical research, particularly in the study of the β-amyloid peptide. His work has implications for understanding and potentially treating conditions such as Alzheimer's disease.

Latest Patents

David Huang holds a patent titled "Method of binding material to the β-amyloid peptide." This invention relates to the discovery that antibodies can bind to the β-amyloid peptide. Furthermore, it reveals that the β-amyloid peptide binds to the hinge region of the immunoglobulin heavy chain, which preserves the immunoglobulin's ability to bind to antigens. The patent also presents methods for binding compounds, such as detectable groups, to the β-amyloid peptide.

Career Highlights

David Huang is affiliated with Duke University, where he continues to engage in innovative research. His work has garnered attention for its potential impact on therapeutic strategies for neurodegenerative diseases. With a total of 1 patent, he exemplifies the spirit of innovation in the academic community.

Collaborations

David has collaborated with notable colleagues, including Allen D. Roses and Dmitry Y. Goldgaber. These partnerships have enriched his research and contributed to advancements in the understanding of β-amyloid peptide interactions.

Conclusion

David Huang's contributions to the field of biomedical research highlight the importance of innovation in addressing complex health challenges. His patent on the β-amyloid peptide is a testament to his dedication to advancing scientific knowledge and improving patient outcomes.